Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4218315
Max Phase: Preclinical
Molecular Formula: C34H47Cl2N5O7S
Molecular Weight: 740.75
Molecule Type: Small molecule
Associated Items:
ID: ALA4218315
Max Phase: Preclinical
Molecular Formula: C34H47Cl2N5O7S
Molecular Weight: 740.75
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)C(=O)NCCCCc1cc(Cl)c(CN2CSC[C@H]2C(=O)N2CCN(C3CC3)c3ccccc32)cc1Cl
Standard InChI: InChI=1S/C34H47Cl2N5O7S/c1-38(17-29(43)31(45)32(46)30(44)18-42)34(48)37-11-5-4-6-21-14-25(36)22(15-24(21)35)16-39-20-49-19-28(39)33(47)41-13-12-40(23-9-10-23)26-7-2-3-8-27(26)41/h2-3,7-8,14-15,23,28-32,42-46H,4-6,9-13,16-20H2,1H3,(H,37,48)/t28-,29-,30+,31+,32+/m0/s1
Standard InChI Key: LYYFIIIMQLYSPV-PCYHVKPNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 740.75 | Molecular Weight (Monoisotopic): 739.2573 | AlogP: 2.28 | #Rotatable Bonds: 15 |
Polar Surface Area: 160.28 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.64 | CX Basic pKa: 3.65 | CX LogP: 1.80 | CX LogD: 1.80 |
Aromatic Rings: 2 | Heavy Atoms: 49 | QED Weighted: 0.15 | Np Likeness Score: -0.70 |
1. Chen T, Reich NW, Bell N, Finn PD, Rodriguez D, Kohler J, Kozuka K, He L, Spencer AG, Charmot D, Navre M, Carreras CW, Koo-McCoy S, Tabora J, Caldwell JS, Jacobs JW, Lewis JG.. (2018) Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5)., 61 (17): [PMID:30141927] [10.1021/acs.jmedchem.8b00308] |
Source(1):